Toll Free: 1-888-928-9744

Ohr Pharmaceutical Inc. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 34 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Ohr Pharmaceutical Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Ohr Pharmaceutical Inc. - Product Pipeline Review - 2014', provides an overview of the Ohr Pharmaceutical Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ohr Pharmaceutical Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Ohr Pharmaceutical Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ohr Pharmaceutical Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Ohr Pharmaceutical Inc.'s pipeline products

Reasons to buy

- Evaluate Ohr Pharmaceutical Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ohr Pharmaceutical Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ohr Pharmaceutical Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ohr Pharmaceutical Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ohr Pharmaceutical Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Ohr Pharmaceutical Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ohr Pharmaceutical Inc. Snapshot 5
Ohr Pharmaceutical Inc. Overview 5
Key Information 5
Key Facts 5
Ohr Pharmaceutical Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Ohr Pharmaceutical Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Ohr Pharmaceutical Inc. - Pipeline Products Glance 10
Ohr Pharmaceutical Inc. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Ohr Pharmaceutical Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Ohr Pharmaceutical Inc. - Drug Profiles 12
OHR/AVR-118 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
squalamine lactate 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Drugs for Allergic Conjunctivitis 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Drugs for Steroid Induced Glaucoma 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Proteins for Retinal Disease 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SKS-1002 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Ohr Pharmaceutical Inc. - Pipeline Analysis 21
Ohr Pharmaceutical Inc. - Pipeline Products by Target 21
Ohr Pharmaceutical Inc. - Pipeline Products by Route of Administration 22
Ohr Pharmaceutical Inc. - Pipeline Products by Molecule Type 23
Ohr Pharmaceutical Inc. - Pipeline Products by Mechanism of Action 24
Ohr Pharmaceutical Inc. - Recent Pipeline Updates 25
Ohr Pharmaceutical Inc. - Dormant Projects 30
Ohr Pharmaceutical Inc. - Discontinued Pipeline Products 31
Discontinued Pipeline Product Profiles 31
squalamine lactate 31
Ohr Pharmaceutical Inc. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34
List of Tables
Ohr Pharmaceutical Inc., Key Information 5
Ohr Pharmaceutical Inc., Key Facts 5
Ohr Pharmaceutical Inc. - Pipeline by Indication, 2014 7
Ohr Pharmaceutical Inc. - Pipeline by Stage of Development, 2014 8
Ohr Pharmaceutical Inc. - Monotherapy Products in Pipeline, 2014 9
Ohr Pharmaceutical Inc. - Phase II, 2014 10
Ohr Pharmaceutical Inc. - Preclinical, 2014 11
Ohr Pharmaceutical Inc. - Pipeline by Target, 2014 21
Ohr Pharmaceutical Inc. - Pipeline by Route of Administration, 2014 22
Ohr Pharmaceutical Inc. - Pipeline by Molecule Type, 2014 23
Ohr Pharmaceutical Inc. - Pipeline Products by Mechanism of Action, 2014 24
Ohr Pharmaceutical Inc. - Recent Pipeline Updates, 2014 25
Ohr Pharmaceutical Inc. - Dormant Developmental Projects,2014 30
Ohr Pharmaceutical Inc. - Discontinued Pipeline Products, 2014 31
Ohr Pharmaceutical Inc., Subsidiaries 32 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify